|Bid||182.73 x 800|
|Ask||182.95 x 1200|
|Day's Range||180.00 - 183.65|
|52 Week Range||177.25 - 220.20|
|Beta (3Y Monthly)||1.38|
|PE Ratio (TTM)||288.06|
|Earnings Date||Oct 23, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||204.93|
Waters Corporation will webcast its Q3 2018 financial results conference call live on Tuesday, October 23rd at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.
The mean rating for Waters Corporation stock is 2.8, and its target price is $205.79, implying an upside potential of 5.7% over its closing price of $194.69 on September 26. In comparison, for peers Danaher (DHR), Stryker (SYK), and Thermo Fisher Scientific (TMO), analysts have mean ratings of 1.83, 1.93, and 1.63, respectively, and target prices of $114.07, $184.43, and $252.86, respectively. From its level of $218.70 on January 29, the stock corrected to $186.44 on August 15.
Waters Corporation (WAT) incurred selling and administrative expenses of $136.6 million in the second quarter compared to $130.1 million in the second quarter of 2017. This increase was attributable to an increase in its head count and merit compensation.
Waters Corporation (WAT) is a specialty measurement company and a pioneer in analytical workflow solutions that involve liquid chromatography, mass spectrometry, and thermal analysis innovations. Additionally, Waters Corporation’s thermal analysis, rheometry, and calorimetry instruments are used in predicting the stability and suitability of fine chemicals, pharmaceuticals, water, polymers, and viscous liquids. Waters Corporation generated total revenue of $596.22 million in the second quarter compared to $558.25 million in the comparable period of 2017.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The rate of growth is weak relative to the trend shown over the past year, however, and is easing.
Waters Corporation (WAT) today opened the doors of the new International Food and Water Research Centre (IFWRC) in Singapore to address the growing challenges of food and water security and safety. Led by a Scientific Advisory Panel, the IFWRC will support scientists throughout the world working in areas such as food authenticity, food fraud discovery, water contamination research, food quality enhancement and new ingredient/formulation studies. The Scientific Advisory Panel will identify meaningful, innovative projects by working with academic and industrial leaders globally.
Waters Corporation Chris O'Connell, Chairman and Chief Executive Officer, will speak to the investment community at the Morgan Stanley 16th Annual Global Healthcare Conference to be held at the Grand Hyatt New York, Wednesday, September 12, at 9:55 AM Eastern Time.
Waters Corporation (WAT) today announced that Linda Baddour, former Chief Financial Officer of PRA Health Sciences Inc., and Gary Hendrickson, former Chairman, President and Chief Executive Officer of Valspar Corporation, have been elected as Directors of Waters Corporation effective September 1, 2018. "I am delighted to welcome both Linda Baddour and Gary Hendrickson to Waters Board of Directors," said Chris O'Connell, Chairman and Chief Executive Officer, Waters Corporation.
The Waters Xevo TQ-GC Mass Spectrometer and Restek Gas Chromatography Consumables Are a Winning Combination for Routine GC-MS Pesticide Residue Analyses and Screening
As the following stock charts of Nektar Therapeutics (NASDAQ:NKTR), Waters (NYSE:WAT) and A.O. Smith (NYSE:AOS) indicate, some stocks are still well-positioned to move higher. Nektar Therapeutics, though, is an exception to that rule of thumb. • A careful look at the daily chart also makes clear that Nektar Therapeutics shares found support at key short-term moving average lines, which is where you’d expect/want to find support.
UNIFI’s Application Programming Interface Pairs with Leading MS Metabolite Identification Processing Software/Platform
Waters (WAT) delivered earnings and revenue surprises of 1.56% and -0.30%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Milford, Massachusetts-based company said it had profit of $1.98 per share. Earnings, adjusted for one-time gains and costs, were $1.95 per share. The results exceeded Wall Street expectations. The ...